Use of the Seer Cancer Registry for Technology Assessment
Published online by Cambridge University Press: 10 March 2009
Abstract
The Surveillance, Epidemiology, and End Results (SEER) cancer registry contributed to technology assessment by providing population-based samples for detailed case-control studies, by serving as the control group in comparisons with various experimental groups, by allowing an assessment of selection bias in clinical trials, and by facilitating evaluations of classification and coding systems.
- Type
- Special Section: The Contribution Of Medical Registries To Technology Assessment
- Information
- International Journal of Technology Assessment in Health Care , Volume 7 , Issue 2 , Spring 1991 , pp. 134 - 142
- Copyright
- Copyright © Cambridge University Press 1991
References
- 7
- Cited by